0.85  0 (0%)		04-15 10:05
Open: 0.85 High: 0.85 Volume: 1		Pre. Close: 0.85 Low: 0.85 Market Cap: 9(M)

Short term
Mid term
Targets	6-month :	2.68	1-year :	3.13
Resists	First :	2.29	Second :	2.68
Pivot price	2.04
Supports	First :	1.86	Second :	1.6
MAs	MA(5) :	2.22	MA(20) :	1.94
	MA(100) :	1.8	MA(250) :	1.95
MACD	MACD :	0.1	Signal :	0.1
%K %D	K(14,3) :	92.8	D(3) :	88
RSI	RSI(14): 71.5
52-week	High :	2.72	Low :	1.39

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ EMITF ] has closed below upper band by 30.1%. Bollinger Bands are 367.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 11 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	2.25 - 2.26	2.26 - 2.27
Low:	2.22 - 2.24	2.24 - 2.25
Close:	2.23 - 2.25	2.25 - 2.27

Elbit Imaging Ltd., together with its subsidiaries, engages in the development, production, and marketing of therapeutic medical systems for performing non-invasive treatments on the human body in the North and South America, Europe, Asia, and Oceania. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was incorporated in 1996 and is headquartered in Petach Tikva, Israel.

Mon, 06 Jan 2020
Charles Koch to invest $200-250m in Insightec - Globes

Sun, 18 Nov 2018
Insightec CEO confident of $30-50 billion exit - Globes - Globes

Thu, 23 Jun 2016
Israeli businessman Motti Zisser, 60, dies - Globes - Globes

Tue, 28 May 2013
Nochi Dankner vs. Jeremy Blank - Globes - Globes

Thu, 01 Nov 2007
Elbit Medical Imaging: Wrong Image! (OTCMKTS:EMITF) - Seeking Alpha

Wed, 24 Apr 2024

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: PNK
Sector: Healthcare
Industry: Medical - Devices
Shares Out	9 (M)
Shares Float	6 (M)
Held by Insiders	37.2 (%)
Held by Institutions	6.8 (%)
Shares Short	4 (K)
Shares Short P.Month	5 (K)

EPS	-8.33
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-6.91
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-4.6 %
Return on Equity (ttm)	-12.2 %
Qtrly Rev. Growth	-30.9 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	-0.28
PEG Ratio	0
Price to Book value	-0.33
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	2021-04-18
Ex-Dividend Date	2021-04-04